5737. Discriminative Accuracy of Chronic Obstructive Pulmonary Disease Screening Instruments in 3 Low- and Middle-Income Country Settings.
作者: Trishul Siddharthan.;Suzanne L Pollard.;Shumonta A Quaderi.;Natalie A Rykiel.;Adaeze C Wosu.;Patricia Alupo.;Julie A Barber.;Maria Kathia Cárdenas.;Ram K Chandyo.;Oscar Flores-Flores.;Bruce Kirenga.;J Jaime Miranda.;Sakshi Mohan.;Federico Ricciardi.;Arun K Sharma.;Santa Kumar Das.;Laxman Shrestha.;Marta O Soares.;William Checkley.;John R Hurst.; .
来源: JAMA. 2022年327卷2期151-160页
Most of the global morbidity and mortality in chronic obstructive pulmonary disease (COPD) occurs in low- and middle-income countries (LMICs), with significant economic effects.
5738. Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial.
作者: Neil A Goldenberg.;John M Kittelson.;Thomas C Abshire.;Marc Bonaca.;James F Casella.;Rita A Dale.;Jonathan L Halperin.;Frances Hamblin.;Craig M Kessler.;Marilyn J Manco-Johnson.;Robert F Sidonio.;Alex C Spyropoulos.;P Gabriel Steg.;Alexander G G Turpie.;Sam Schulman.; .
来源: JAMA. 2022年327卷2期129-137页
Among patients younger than 21 years of age, the optimal duration of anticoagulant therapy for venous thromboembolism is unknown.
5739. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial.
作者: Domenica M Rubino.;Frank L Greenway.;Usman Khalid.;Patrick M O'Neil.;Julio Rosenstock.;Rasmus Sørrig.;Thomas A Wadden.;Alicja Wizert.;W Timothy Garvey.; .
来源: JAMA. 2022年327卷2期138-150页
Phase 3 trials have not compared semaglutide and liraglutide, glucagon-like peptide-1 analogues available for weight management.
|